Details of the Drug

General Information of Drug (ID: DMM4A19)

• Drug Name: SAR422459

Indication

Disease Entry	ICD 11	Status	REF
Stargardt disease	9B70	Phase 1/2	[1]

• Cross-matching ID: TTD ID: D0KL4E

References

• [1] ClinicalTrials.gov (NCT01367444) Phase I/IIa Study of StarGen in Patients With Stargardt's Macular Degeneration. U.S. National Institutes of Health.